Literature DB >> 5834227

Serum complement levels in rheumatoid arthritis. A longitudinal study of 43 cases with correlation of clinical and serological data including rheumatoid factor and thermolabile inhibitor of the F-II L.P. test.

A F Schubart, R W Ewald, W C Schroeder, H J Rothschild, D N Bhatavadekar, P K Pullen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5834227      PMCID： PMC1031008          DOI： 10.1136/ard.24.5.439

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  Complement, complement components, properdin and agglutination promoting factors in rheumatoid arthritis.

Authors:  A B LAURELL; R GRUBB
Journal:  Acta Pathol Microbiol Scand       Date:  1958

2.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

3.  Complement and complement components in diseases of possible auto-immunological pathogenesis.

Authors:  J JONSEN; E KASS
Journal:  Acta Rheumatol Scand       Date:  1961

4.  Serum complement levels in systemic lupus erythematosus and other diseases.

Authors:  G L ASHERSON
Journal:  Australas Ann Med       Date:  1960-02

5.  Serum complement in connective tissue disorders.

Authors:  R C WILLIAMS; D H LAW
Journal:  J Lab Clin Med       Date:  1958-08

6.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

7.  Complementary activity of the blood in rheumatism and certain allied disorders.

Authors:  C E KELLETT
Journal:  Ann Rheum Dis       Date:  1954-09       Impact factor: 19.103

8.  Serum complement in rheumatoid arthritis.

Authors:  J H VAUGHAN; T B BAYLES; C B FAVOUR
Journal:  Am J Med Sci       Date:  1951-08       Impact factor: 2.378

9.  Complement in Health and in Disease.

Authors:  F T Cadham
Journal:  Can Med Assoc J       Date:  1926-04       Impact factor: 8.262

10.  Serum complement, rheumatoid factor, and other serum proteins in rheumatoid disease and systemic lupus erythematosus.

Authors:  H A ELLIS; D FELIX-DAVIES
Journal:  Ann Rheum Dis       Date:  1959-09       Impact factor: 19.103
View more
  8 in total

1.  Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.

Authors:  V A Makinde; G Senaldi; A S Jawad; H Berry; D Vergani
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

2.  Serum immunoglobulin and beta 1C-beta 1A globulin concentrations in juvenile rheumatoid arthritis.

Authors:  K M Goel; R W Logan; W P Barnard; R A Shanks
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

3.  Quantitative aspects of the latex-fixation and Whaaler-Rose tests.

Authors:  A Cats; F Klein
Journal:  Ann Rheum Dis       Date:  1970-11       Impact factor: 19.103

4.  Standardized, automated procedure for measurement of serum hemolytic complement activity.

Authors:  I Olitzky
Journal:  Appl Microbiol       Date:  1968-11

5.  Complement metabolism in rheumatoid arthritis. I. Longitudinal studies.

Authors:  J M Versey; J R Hobbs; P J Holt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

6.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  Metabolism of factor B of serum complement in rheumatoid arthritis.

Authors:  E H Krick; D H De Heer; R A Kaplan; C M Arroyave; J H Vaughan
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

Review 8.  Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5.

Authors:  S Yoshinoya; R M Pope
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.